Biotech · Private company

VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Track this companyFree. Adds VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) to your Dealase workspace and tells you when its record changes.

Clinical trials20 recruiting or active

Pipeline programs2From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline2

Zilovertamab vedotinPhase 2 · Triple-negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Zilovertamab vedotinPhase 1 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials2

A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)PHASE2 · TERMINATED · started Oct 7, 2020ClinicalTrials.gov NCT04504916 · fetched Nov 12, 2026
A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)PHASE1 · COMPLETED · started Mar 14, 2019ClinicalTrials.gov NCT03833180 · fetched Nov 12, 2026